High-Dose 1-Beta-D-Arabinofuranosylcytosine in Advanced Breast Cancer
- 1 January 1985
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 42 (5) , 273-274
- https://doi.org/10.1159/000226045
Abstract
Twenty-two patients with metastatic breast cancer refractory to conventional chemotherapeutic agents were treated with 1-β-D-arabinofuranosylcytosine (Ara-C) at a dose of 2 g/m2 over 2 h every 12 h for 3 doses at 21-day intervals. Two patients achieved partial remission, 3 patients had less than partial response.Keywords
This publication has 6 references indexed in Scilit:
- VINBLASTINE GIVEN AS A CONTINUOUS 5-DAY INFUSION IN THE TREATMENT OF REFRACTORY ADVANCED BREAST-CANCER1980
- Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug TherapyAnnals of Internal Medicine, 1979
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- CORRELATION BETWEEN LEUKEMIC CELL RETENTION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE AND RESPONSE TO THERAPY1979
- VINDESINE - PHASE-II STUDY IN TREATMENT OF BREAST CARCINOMA, MALIGNANT-MELANOMA, AND OTHER TUMORS1978
- Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on SurvivalAnnals of Internal Medicine, 1976